Otilimab
Otilimab (GSK 3196165) is an anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) human monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor[1].
Product Specifications
CAS Number
[1638332-55-4]
Product Name Alternative
GSK 3196165; MOR103
UNSPSC
12352203
Target
C-Fms
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/otilimab.html
Purity
99.29
Solubility
10 mM in DMSO
Smiles
[Otilimab]
Molecular Weight
(142.22 kDa)
References & Citations
[1]Senolt L. Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies. F1000Res. 2019 Aug 30;8:F1000 Faculty Rev-1549.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7096948-01 0.02 mg (E-Coli)
Recombinant Human Piezo-type mechanosensitive ion channel component 1 (PIEZO1) , partial
Ask
View Details 
MBS7096948-02 0.1 mg (E-Coli)
Recombinant Human Piezo-type mechanosensitive ion channel component 1 (PIEZO1) , partial
Ask
View Details MBS7096948-03 0.02 mg (Yeast)
Recombinant Human Piezo-type mechanosensitive ion channel component 1 (PIEZO1) , partial
Ask
View Details